Cost-effectiveness Analysis of Sacubitril/Valsartan vs Enalapril in Patients With Heart Failure and Reduced Ejection Fraction.

Cost-effectiveness Analysis of Sacubitril/Valsartan vs Enalapril in Patients With Heart Failure and Reduced Ejection Fraction. JAMA Cardiol. 2016 09 01; 1(6):666-72.

View in: PubMed

subject areas

Aminobutyrates
Angiotensin Receptor Antagonists
Angiotensin-Converting Enzyme Inhibitors
Biphenyl Compounds
Cost-Benefit Analysis
Drug Combinations
Enalapril
Female
Heart Failure
Humans
Male
Middle Aged
Quality of Life
Stroke Volume
Tetrazoles
Valsartan

authors with profiles

Michael R. Zile